tiprankstipranks
Upstream Bio, Inc. (UPB)
NASDAQ:UPB
US Market
UPB
Upstream Bio, Inc.
RESEARCH TOOLSreports
Want to see UPB full AI Analyst Report?

Upstream Bio, Inc. (UPB) Financial Statements

262 Followers

Upstream Bio, Inc. Financial Overview

Upstream Bio, Inc.'s market cap is currently $505.56M. The company's EPS TTM is $-0.78; its P/E ratio is -10.19; Upstream Bio, Inc. is scheduled to report earnings on March 18, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 2.85M$ 2.37M$ 2.38M$ 1.21M
Gross Profit$ 2.67M$ 2.37M$ 2.38M$ 1.21M
Operating Income$ -160.36M$ -77.76M$ -40.11M$ -23.91M
EBITDA$ -160.36M$ -77.67M$ -40.05M$ -23.90M
Net Income$ -143.44M$ -62.81M$ -20.54M$ -23.87M
Balance Sheet
Cash & Short-Term Investments$ 341.51M$ 470.45M$ 109.81M$ 17.05M
Total Assets$ 353.77M$ 481.72M$ 117.20M$ 18.48M
Total Debt$ 1.27M$ 1.83M$ 45.00K$ 94.00K
Net Debt$ -100.31M$ -324.06M$ -25.79M$ -16.96M
Total Liabilities$ 14.00M$ 11.87M$ 240.32M$ 124.63M
Stockholders' Equity$ 339.77M$ 469.85M$ -123.13M$ -106.16M
Cash Flow
Free Cash Flow$ -133.28M$ -59.68M$ -38.07M$ -19.10M
Operating Cash Flow$ -133.28M$ -59.17M$ -37.93M$ -19.02M
Investing Cash Flow$ -93.48M$ -59.48M$ -82.84M$ -82.00K
Financing Cash Flow$ 2.44M$ 418.91M$ 129.55M$ 9.96M
Currency in USD

Upstream Bio, Inc. Earnings and Revenue History

Income Statement >

Upstream Bio, Inc. Debt to Assets

Balance Sheet >

Upstream Bio, Inc. Cash Flow

Cash Flow >

Upstream Bio, Inc. Forecast EPS vs Actual EPS

Earnings >